UA117673C2 - Поліміксини, композиція, спосіб одержання і спосіб застосування (варіанти) - Google Patents

Поліміксини, композиція, спосіб одержання і спосіб застосування (варіанти)

Info

Publication number
UA117673C2
UA117673C2 UAA201507907A UAA201507907A UA117673C2 UA 117673 C2 UA117673 C2 UA 117673C2 UA A201507907 A UAA201507907 A UA A201507907A UA A201507907 A UAA201507907 A UA A201507907A UA 117673 C2 UA117673 C2 UA 117673C2
Authority
UA
Ukraine
Prior art keywords
methods
polymyxins
compositions
making
сн2сн3
Prior art date
Application number
UAA201507907A
Other languages
English (en)
Ukrainian (uk)
Inventor
Сьольві Гуннес
Відар Бьйонстад
Торбен Кох
Клес Меландер
Мартін Монссон
Original Assignee
Кселлія Фармасьютікалз Апс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кселлія Фармасьютікалз Апс filed Critical Кселлія Фармасьютікалз Апс
Publication of UA117673C2 publication Critical patent/UA117673C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
UAA201507907A 2013-01-11 2014-01-09 Поліміксини, композиція, спосіб одержання і спосіб застосування (варіанти) UA117673C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361751341P 2013-01-11 2013-01-11
US201361904793P 2013-11-15 2013-11-15
PCT/EP2014/050320 WO2014108469A1 (en) 2013-01-11 2014-01-09 Polymyxins, compositions, methods of making and methods of use

Publications (1)

Publication Number Publication Date
UA117673C2 true UA117673C2 (uk) 2018-09-10

Family

ID=50101865

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201507907A UA117673C2 (uk) 2013-01-11 2014-01-09 Поліміксини, композиція, спосіб одержання і спосіб застосування (варіанти)

Country Status (20)

Country Link
US (1) US10640536B2 (enExample)
EP (1) EP2943503B1 (enExample)
JP (1) JP6316846B2 (enExample)
KR (1) KR20150107793A (enExample)
CN (1) CN104918951B (enExample)
AU (1) AU2014204873B2 (enExample)
BR (1) BR112015016548A2 (enExample)
CA (1) CA2895910C (enExample)
EA (1) EA027067B1 (enExample)
ES (1) ES2641017T3 (enExample)
HU (1) HUE034562T2 (enExample)
IL (1) IL239840A (enExample)
MX (1) MX360905B (enExample)
PT (1) PT2943503T (enExample)
RU (1) RU2015132569A (enExample)
SI (1) SI2943503T1 (enExample)
TW (1) TWI613219B (enExample)
UA (1) UA117673C2 (enExample)
WO (1) WO2014108469A1 (enExample)
ZA (1) ZA201504565B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA027067B1 (ru) 2013-01-11 2017-06-30 Кселлия Фармасьютикалз Апс Полимиксины, композиции, способы получения и способы применения
TW201522364A (zh) * 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
JP2017523953A (ja) 2014-07-09 2017-08-24 クセリア ファーマシューティカルズ エーピーエスXellia Pharmaceuticals ApS 低置換度ポリミキシン及びその組成物
RS60874B1 (sr) 2014-10-03 2020-11-30 Xellia Pharmaceuticals Aps Kompozicije
SG11201702666SA (en) 2014-10-03 2017-04-27 Xellia Pharmaceuticals Aps Inhalation device
WO2016100578A2 (en) 2014-12-16 2016-06-23 Micurx Pharmaceuticals, Inc. Antimicrobial polymyxins for treatment of bacterial infections
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
AU2016331658B2 (en) * 2015-09-29 2021-04-01 Monash University Antimicrobial polymyxin derivative compounds
CN109996806B (zh) * 2016-12-09 2021-11-02 正大天晴药业集团股份有限公司 高效价的多黏菌素e2甲磺酸钠
CN115298198A (zh) 2020-01-21 2022-11-04 上海盟科药业股份有限公司 用于肾相关癌症靶向治疗的新型化合物和组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1062895A (en) 1962-12-13 1967-03-22 Wellcome Found Sulphomethyl derivatives of polymxin
FR1586834A (enExample) 1968-02-12 1970-03-06
DE1906699A1 (de) 1968-02-12 1970-02-05 Pfizer Neue Polymyxinderivate und Verfahren zu deren Herstellung
EP0362370A1 (en) * 1988-04-07 1990-04-11 Edward Shanbrom Non-thrombogenic intravascular time release catheter
ATE202481T1 (de) 1996-11-15 2001-07-15 Pathogenesis Corp Reines, biologisch aktives colistin, seine bestandteile und eine colistin-zubereitung zur behandlung von entzündungen der atemwege
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
ES2261735T3 (es) 2001-05-18 2006-11-16 Chiron Corporation Sistema para la administracion de una formulacion de tobramicina.
US20040022740A1 (en) 2001-07-10 2004-02-05 Baker William R. Macrolide formulations for inhalation and methods of treatment of endobronchial infections
EP1940859A1 (en) * 2005-10-28 2008-07-09 Arch Pharmalabs Limited An improved process for preparation of gemcitabine hydrochloride
WO2008025560A1 (en) 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
EA027067B1 (ru) 2013-01-11 2017-06-30 Кселлия Фармасьютикалз Апс Полимиксины, композиции, способы получения и способы применения
TW201522364A (zh) 2013-06-07 2015-06-16 Xellia Pharmaceuticals Aps 黏菌素甲磺酸鈉(cms)之定性方法
JP2017523953A (ja) 2014-07-09 2017-08-24 クセリア ファーマシューティカルズ エーピーエスXellia Pharmaceuticals ApS 低置換度ポリミキシン及びその組成物
RS60874B1 (sr) 2014-10-03 2020-11-30 Xellia Pharmaceuticals Aps Kompozicije

Also Published As

Publication number Publication date
KR20150107793A (ko) 2015-09-23
EP2943503A1 (en) 2015-11-18
RU2015132569A (ru) 2017-02-14
CN104918951A (zh) 2015-09-16
ES2641017T3 (es) 2017-11-07
JP2016505007A (ja) 2016-02-18
SI2943503T1 (sl) 2017-11-30
CA2895910A1 (en) 2014-07-17
US10640536B2 (en) 2020-05-05
MX360905B (es) 2018-11-21
TW201429995A (zh) 2014-08-01
US20160002296A1 (en) 2016-01-07
CA2895910C (en) 2021-12-21
AU2014204873A1 (en) 2015-07-09
AU2014204873B2 (en) 2017-07-06
MX2015008878A (es) 2015-10-30
IL239840A (en) 2017-09-28
IL239840A0 (en) 2015-08-31
EA201591280A1 (ru) 2015-12-30
HUE034562T2 (en) 2018-03-28
JP6316846B2 (ja) 2018-04-25
EA027067B1 (ru) 2017-06-30
EP2943503B1 (en) 2017-08-23
CN104918951B (zh) 2018-03-30
TWI613219B (zh) 2018-02-01
WO2014108469A1 (en) 2014-07-17
ZA201504565B (en) 2016-11-30
PT2943503T (pt) 2017-09-28
BR112015016548A2 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
UA117673C2 (uk) Поліміксини, композиція, спосіб одержання і спосіб застосування (варіанти)
CU20170164A7 (es) Compuestos n-tieno (2,3-d)pirimidinil-d-fenilalanina, método para preparar los mismos y composiciones farmacéuticas que los contienen
CY1120188T1 (el) ΠΑΡΑΓΩΓΑ ΝΑΦΘΥΡΙΔΙΝΗΣ ΧΡΗΣΙΜΑ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ ΙΝΤΕΓΚΡΙΝΗΣ αvβ6
EA201691085A1 (ru) Замещенные бензамиды и способы их применения
MY182568A (en) Quaternary ammonium compounds and their use as fuel or lubricant additives
EA201791584A1 (ru) Агрохимическая композиция
CU24377B1 (es) Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting
MX351581B (es) Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen.
ES2626555T3 (es) Pyridone amides como moduladores de canales de sodio
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
CR20170118A (es) Derivados espirodiamina como inhibidores de la aldosterona sintasa
MX381608B (es) Amida/éster de bajo peso molecular que contiene sales de amonio cuaternario.
SG10201805628TA (en) Deuterated heterocyclic compounds and their use as imaging agents
WO2016077464A8 (en) Amino acid derivatives and their uses
MA38982A1 (fr) Nouvel octahydro-cyclobuta [1,2-c; 3,4-c'] dipyrrol-2-yl
DOP2014000178A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
MX2016005993A (es) Anfifilos biscationicos y triscationicos como agentes antimicrobianos.
BR112018001980A2 (pt) compostos cíclicos úteis como moduladores de tnf alfa
MX2016014239A (es) Composicion limpiadora.
SG10201805896SA (en) PPARγ AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS
MY182549A (en) Ether compounds and related compositions
MY166229A (en) Nonwoven fabric and textile treating agent
MX2016014240A (es) Composicion limpiadora.
PH12016501343B1 (en) Emulsion composition for skin